The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.
New clinical trials for brain tumors and metastases are currently open for enrollment at the Pacific Neuroscience Institute. Contact us at 310-829-8265.